Navigation Links
Telik Announces Initiation of a Phase 2b Clinical Trial of Telintra® (Ezatiostat HCL) in Patients With Low to Intermediate-1 Risk Non-Deletion (5q) Myelodysplastic Syndrome
Date:10/13/2011

of MDS.  Telintra has the potential for combining with other agents used to treat MDS.  Telintra has been well-tolerated with mostly grade 1 or 2 gastrointestinal side effects.

Background on MDS and Telintra

The myelodysplastic syndrome is a heterogeneous group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis (blood cell production) involving one or more cell lineages (red blood cells, white blood cells or platelets) and a variable risk of transformation to acute myeloid leukemia.  It is estimated that MDS affects approximately 300,000 people worldwide. According to the American Cancer Society, 10,000–20,000 new cases of MDS are diagnosed each year in the United States, with survival rates ranging from six months to six years. MDS patients often require multiple blood transfusions to manage their disease.

Telintra has a novel mechanism of action that inhibits an enzyme called glutathione S-transferase P1-1, which leads to activation of Jun kinase, a key regulator of cellular growth and differentiation of blood precursor cells; and induces cancer cell death, or apoptosis, in human leukemia cell lines. Telintra is also being evaluated in a Phase 2 clinical study in Revlimid® refractory and resistant deletion 5q MDS patients.  Additional information about Telintra is available at www.telik.com.

About Telik, Inc.

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer. The company's most advanced drug candidate is Telintra®, a modified glutathione analog intended for the treatment of hematologic disorders including myelodysplastic syndrome; followed by Telcyta®, a cancer activated prodrug for the treatment of a variety of cancers. Telik's product candidates were discovered using its proprietary drug discovery tech
'/>"/>

SOURCE Telik, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Telik Announces Publication in the Journal Cancer of a Phase 2 Randomized Multicenter Study of Two Extended Dosing Schedules of Oral Ezatiostat in Low to Intermediate-1 Risk Myelodysplastic Syndrome
2. Telik Announces First Quarter 2011 Financial Results
3. Telik Announces Presentation of New Data on the Characterization of Novel Ezatiostat (TELINTRA®, TLK199) Analogs at American Association for Cancer Research Annual Meeting
4. Telik Announces Presentation and Webcast at 10th Annual Needham Healthcare Conference
5. Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance
6. Telik Announces Presentation and Webcast at 13th Annual BIO CEO & Investor Conference
7. Telik Announces Presentation at American Society of Hematology Annual Meeting
8. Telik Announces Third Quarter 2010 Financial Results
9. Telik Awarded $1.2 Million in Grants for Qualifying Therapeutic Development Projects
10. Telik Announces Publication of Review Focused on the Inhibition of the Enzyme GSTP1-1 as a Target for New Cancer Treatments
11. Telik Announces Publication of a Case Report of a Sustained Hematologic Response in Myelodysplastic Syndrome Following an Abbreviated Exposure to Oral Telintra(R) (Ezatiostat HCl)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)...   Assurex Health, a personalized medicine company ... for behavioral health and chronic pain conditions, today ... equity financing from new and existing investors, according ... Chief Executive Officer. The financing will ... Health,s GeneSight ®  products.  GeneSight,s patented ...
(Date:12/24/2014)... Dec. 23, 2014 Tianyin Pharmaceutical Co., ... specializes in patented biopharmaceutical, modernized traditional Chinese medicine ... today announced that the Company achieved the Public ... Practice (GMP) certificate of TPI,s Qionglai Facility (QLF) ... The public notice period is a significant procedure ...
(Date:12/24/2014)... CHAPEL HILL, N.C. , Dec. 23, 2014 /PRNewswire/ ... marketplace success. As the key link between the medical ... will grow even more in the coming years as ... relationships. According to research by benchmarking ... and MSLs can gain an important edge is by ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3Role of Medical Science Liaisons Evolving in Medical Device Sector 2
(Date:12/24/2014)... nearly 20 years, June Cotner has been the go-to ... life's rites of passage. Here, she joins forces with ... Toasts: The Perfect Words to Celebrate Every Occasion , ... and containing many original toasts written just for this ... contains sayings famous and profound, suitable and sentimental. Covering ...
(Date:12/24/2014)... December 24, 2014 “ Relax Melodies ... monthly AppWatch, which features the latest and coolest mobile ... Tropeano, a mobile technology expert and host of NewsWatch, ... this application soothes users so they can fall asleep. ... of adults say they have some sort of difficulty ...
(Date:12/24/2014)... As 2014 draws to a close, ... time and money into a new or tankless water ... in tankless and eco-friendly products or service. Greenstar urges ... in 2015 to research “green” and environmentally friendly options ... Services specializes in eco-friendly and environmentally conscious products ...
(Date:12/24/2014)... 24, 2014 Dr. Ronald Receveur, a ... experience placing dental implants in a day, ... effects of overusing teeth-whitening treatments. , In his ... , Dr. Receveur writes that overusing teeth-whitening treatments can ... damage to enamel. , “Because teeth-whitening treatments ...
(Date:12/24/2014)... Kathleen Doheny HealthDay Reporter ... steady diet of fast food might hurt your child in ... ate fast food in fifth grade lagged behind by eighth ... more than 8,500 U.S. students. "The largest effects were ... food," said study leader Kelly Purtell, assistant professor of human ...
Breaking Medicine News(10 mins):Health News:An Application to Help with Insomnia was Featured on NewsWatch Television on December 19, 2014 2Health News:Greenstar Home Services Offers Tankless Water Heater Advice to Local Homeowners 2Health News:New Albany Dentist Weighs In On New Trend of Overbleaching Teeth 2Health News:New Albany Dentist Weighs In On New Trend of Overbleaching Teeth 3Health News:Can Fast Food Hinder Learning in Kids? 2
... in French . Montreal, September 1, 2009 ... bacteria from the skin of the fruit, holds great promise ... the International Journal of Obesity , was conducted by ... the Universit de Moncton who tested the effects of biotransformed ...
... , , CHICAGO, Sept. 1 ... launched a new online video series, called " Living Positive By ... and AIDS education initiative. The Living Positive By Design ... to encourage thoughtful conversations about HIV and AIDS, to confront HIV ...
... , SEARCY, Ark., Sept. 1 Fourteen ... this year,s National Day of Encouragement with the first ever "7 ... The tour will launch September 5 in San Francisco and conclude ... and commemoration of the third annual National Day of Encouragement in ...
... , WASHINGTON, Sept. 1 The ... Tobacco-Free Kids: , , (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) ... Tobacco Company, Lorillard Inc. and other tobacco manufacturers that they have ... legislation is not unexpected. The lawsuit, filed in the federal court ...
... , CINCINNATI, Sept. 1 ... physician office-based patient-education programs has announced that SIGVARIS, the ... expanding to the Skin Care Network to broaden their ... office is an ideal place to increase the awareness ...
... MILFORD, Mass., Sept. 1 Waters Corporation (NYSE: ... Division of the American Chemical Society presented Prof. John R. ... Achievements by a Young Analytical Scientist. Through a ... the combined use of hydrogen-deuterium (H/D) exchange technology ...
Cached Medicine News:Health News:Biotransformed blueberry juice fights fat and diabetes 2Health News:Video: 'Project Runway' Designer Launches New Online Video Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma 2Health News:Video: 'Project Runway' Designer Launches New Online Video Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma 3Health News:'7 Days Across America' Campaign Honors Teens Making a Difference in Their Communities 2Health News:'7 Days Across America' Campaign Honors Teens Making a Difference in Their Communities 3Health News:'7 Days Across America' Campaign Honors Teens Making a Difference in Their Communities 4Health News:RJR, Other Tobacco Companies Go to Court to Evade Regulation by FDA 2Health News:SIGVARIS USA Extends Educational Efforts in Healthy Advice's Skin Care Network 2Health News:SIGVARIS USA Extends Educational Efforts in Healthy Advice's Skin Care Network 3Health News:American Chemical Society Awards John R. Engen for Scientific Achievements 2Health News:American Chemical Society Awards John R. Engen for Scientific Achievements 3
... is established. Provides a robust and durable ... positioning on the globe. Pressure Ridge Molteno ... covered by Tenons tissue, acts as a ... The range of implants allows the surgeon ...
... implant is the first glaucoma implant designed ... pars plana vitrectomy. The Hoffman Elbow was ... gauge pars plana sclerostemy incision. Baerveldt Glaucoma ... the largest surface area in a streamlined ...
... enough to shuttle easily between offices in ... a goldmann standard 30 cm radius bowl. ... locations (including 30-2, 24-2, and 10-2) to ... out to 30. Easyfield is so ...
... 311 has additional hardware and software features ... most demanding clinics or teaching institutions. Standard ... test parameters for experimental or clinical studies. ... Capacity for further tests including Flicker- and ...
Medicine Products: